ORKA-002 HS PK simulation
Indication: Hidradenitis suppurativa
Interactive ORKA-002 PK simulator for hidradenitis suppurativa using a pragmatic one-compartment SC biologic model calibrated to HS-adjusted PK summary values.
Drug Overview
Clinical Context
- Molecular Target
- IL-17A / IL-17F
- Drug Class
- Humanized IgG1 monoclonal antibody against IL-17A / IL-17F
- Therapeutic Area
- Dermatology / Immunology
- Indication
- Hidradenitis suppurativa
- Route of Administration
- Subcutaneous
Model Information
- Model Type
- 1-compartment SC PopPK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for ORKA-002 HS allows you to explore concentration-time profiles under different dosing scenarios. The underlying 1-compartment SC PopPK model characterizes the pharmacokinetics of this humanized igg1 monoclonal antibody against il-17a / il-17f following subcutaneous administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the ORKA-002 HS PK simulator?
This is a free, interactive pharmacokinetic simulator for ORKA-002 HS used in Hidradenitis suppurativa. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does ORKA-002 HS belong to?
ORKA-002 HS is classified as a Humanized IgG1 monoclonal antibody against IL-17A / IL-17F that targets IL-17A / IL-17F. It is used in the Dermatology / Immunology therapeutic area.
What route of administration does this model simulate?
This simulator models Subcutaneous administration of ORKA-002 HS. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a 1-compartment SC PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Ready to Simulate?
Launch the ORKA-002 HS simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community